STAT

DECEMBER 13, 2023

Pfizer said Wednesday that its 2024 profits would fall far below investor expectations, leading shares to tumble 7% in early trading. Pfizer said that its full-year revenue for 2024 should fall between $58.5 The reduced earnings numbers cap a difficult year for the drug giant. billion and $61.5

Vaccines 233

Vaccines 233

STAT

SEPTEMBER 6, 2022

Because Pfizer and Moderna hold the patents for the current vaccines, researchers would likely have to get the companies’ permission to use them for research into products like nasal or pan-coronavirus vaccines. Right now, Pfizer isn’t sharing its vaccines for research purposes, a spokesperson confirmed to STAT.

Vaccines 363

Vaccines 363

BioPharma Dive

MAY 7, 2024

Pfizer said the patient, a young boy who was treated earlier last year, had died suddenly. The company is working with trial researchers to investigate further.

142

142

STAT

JANUARY 27, 2023

After weeks of deliberation, Pfizer was scolded by a U.K. The fracas began when the Pfizer chief, Albert Bourla, gave an interview to the BBC and discussed the idea of vaccinating children between five and 11 years old, a course of action that had not yet been approved by regulators in the U.K.

Vaccines 363

Vaccines 363

STAT

DECEMBER 1, 2023

Pfizer on Friday said it was stopping development of a twice-daily oral obesity medication after an underwhelming clinical trial, a blow to the company’s efforts to compete in the booming field of weight-loss medications.

Drug Development 255

Drug Development 255

STAT

MARCH 20, 2024

Johnson & Johnson has accused a long-standing employee of taking thousands of confidential files about commercial strategies as he left for a similar job at Pfizer, according to lawsuit filed in a federal court in New Jersey.

Documentation 244

Documentation 244

STAT

JULY 18, 2023

Pharma giant Pfizer is turning to venture firm Flagship for new drug development, signing a deal worth up to $7 billion to mine new medicines from the latter’s portfolio companies. Flagship and Pfizer announced Tuesday that they will each put $50 million into developing up to 10 drug candidates.

Drug Development 230

Drug Development 230

STAT

OCTOBER 11, 2023

A company that Pfizer blamed for problems with a clinical trial testing a Lyme vaccine claims that regulators gave its procedures a clean bill of health during a recent inspection. Care Access served as a contract research organization and had enrolled about 3,000 patients in the late-stage trial.

Vaccines 223

Vaccines 223

STAT

MARCH 1, 2024

New data from the Centers for Disease Control and Prevention and the Food and Drug Administration suggest what appears to be an elevated rate of GBS, as the condition is called, among people who got the Pfizer vaccine, although there were also cases detected among people who got the GSK product.

Vaccines 182

Vaccines 182

STAT

AUGUST 31, 2022

The Food and Drug Administration on Wednesday authorized new Covid booster shots from Moderna and Pfizer that more closely match the strains of the coronavirus that are currently circulating in the U.S. Pfizer’s booster, made with partner BioNTech, is being authorized for people as young as 12 years old.

Vaccines 249

Vaccines 249

STAT

JULY 28, 2023

AstraZeneca said Friday it will buy up a group of early-stage gene therapies from Pfizer, bucking a trend of drugmakers axing programs and exiting a field that had once captured the imagination — and checkbooks — of many pharmaceutical executives. The companies did not say how much it is paying upfront.

208

208

STAT

JULY 20, 2023

Among the damaged buildings was a Pfizer plant in Rocky Mountain, N.C. A Pfizer spokesperson said the company is trying to determine the impact on production, but told us further details are not yet available. and around the world to obtain needed medicines the next time they visit a hospital.

Compounding 235

Compounding Hospitals 235

pharmaphorum

MAY 23, 2024

China’s Asymchem Laboratories has agreed to take over the operation of a Pfizer manufacturing facility in Sandwich, UK, saving dozens of jobs.

96

96

STAT

NOVEMBER 21, 2023

The Texas attorney general is suing Pfizer over allegedly selling ineffective ADHD medicines to the state’s Medicaid program, Reuters tells us. Pfizer did not immediately comment on the allegations, according to Reuters. MorphoSys intends to file pelabresib for regulatory approval, but analysts are skeptical of its future.

184

184

STAT

MARCH 13, 2023

Pfizer said Monday it is acquiring Seagen, a maker of targeted cancer drugs, for $43 billion. The deal helps Pfizer, flush with cash but in need of new sources of revenue due to declining sales of Covid treatments, by adding a lineup of cancer drugs called antibody-drug conjugates that work by delivering chemotherapy directly to tumors.

Chemotherapy 207

Chemotherapy 207

STAT

MARCH 9, 2023

WASHINGTON — Pfizer CEO Albert Bourla made the maximum possible campaign contribution to Mehmet Oz ahead of his failed bid last year to represent Pennsylvania in the U.S. Senate, according to federal campaign finance records.

Pharmaceutical Companies 321

Pharmaceutical Companies Pharmaceutical Companies 321

STAT

NOVEMBER 18, 2022

BOSTON — As Pfizer prepares to hike the price of its Covid-19 vaccines, the company’s CEO, Albert Bourla, maintained at a conference this week that the jabs will continue to be “free for all Americans” because insurers are required to pay the extra cost. ” Read the rest…

Vaccines 261

Vaccines 261

STAT

JUNE 29, 2023

A former Pfizer statistician on Thursday was charged by U.S. Securities and Exchange Commission alleged that Amit Dagar, 43, who had been a senior statistical program lead for the trial, traded Pfizer stock before results became public on Nov.

Hospitals 208

Hospitals 208

Pharmaceutical Technology

APRIL 24, 2024

Pfizer and its Germany partner BioNTech have urged London’s High Court to invalidate competitor Moderna's patents over technology instrumental in the Covid-19 vaccines development as the latest phase of a global legal fight that started yesterday (23 April), reported Reuters.

Vaccines 130

Vaccines 130

Express Pharma

JANUARY 31, 2024

Pfizer and Glenmark Pharmaceuticals have joined hands to launch abrocitinib, an oral advanced systemic treatment for moderate-to-severe atopic dermatitis (AD), in India. When launched in India, it will be co-marketed under the brand names JABRYUS and CIBINQO by Glenmark and Pfizer respectively.

115

115

Express Pharma

MAY 12, 2024

Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year’s annual ‘Choose France’ business summit. Pfizer said it would invest 500 million euros ($538.5

80

80

pharmaphorum

MAY 7, 2024

Pfizer has paused dosing in a study of its Duchenne muscular dystrophy gene therapy after a sudden patient death in another trial

109

109

STAT

OCTOBER 19, 2023

… Pfizer will price a course of its Covid-19 drug Paxlovid at nearly $1,400 when commercial sales begin later this year, more than double what the U.S. Pfizer has already faced criticism from doctors and patient advocates that raising the price will limit patient access. As always, we hope your day is meaningful and productive.

Drug Pricing 226

Drug Pricing 226

STAT

MAY 9, 2024

… Pfizer agreed to settle more than 10,000 cases accusing it of hiding cancer risks of its Zantac heartburn drug, Bloomberg News reports. Meanwhile, here is the latest menu of tidbits for you to digest as you embark on your journey, which we hope is satisfying and rewarding. On that note, time to get cracking.

191

191

STAT

JULY 21, 2023

Pfizer says a tornado that ripped through a key manufacturing plant in North Carolina does not appear to have caused “any major damage” to areas that produce medicines. The Rocky Mount site is one of 10 Pfizer manufacturing sites located in the U.S. and abroad. Continue to STAT+ to read the full story…

Packaging 207

Packaging Hospitals 207

PharmaVoice

MARCH 11, 2024

With COVID-19 vaccine sales dying down, Pfizer and Moderna turn to growth in different ways to cement their status as mRNA leaders.

Vaccines 130

Vaccines 130

STAT

FEBRUARY 17, 2023

Pfizer and partner Valneva are scrapping data from roughly half of the participants in a Phase 3 trial of a Lyme disease vaccine candidate after uncovering quality issues with a third-party clinical trial operator. Continue to STAT+ to read the full story…

Vaccines 227

Vaccines 227

Pharmaceutical Technology

FEBRUARY 12, 2024

The UK MHRA has granted approval for a variation in licence of Pfizer-BioNTech’s Comirnaty XBB.1.5 vaccine targeting Omicron variant.

Vaccines 142

Vaccines 142

STAT

JANUARY 30, 2023

lawmakers have asked Pfizer not to raise the price of its Covid-19 vaccine, citing concerns such a move could strain the U.K. In a letter to Pfizer chief executive officer Albert Bourla, the lawmakers noted the company plans to raise the price of its shot to $110 to $130 a dose in the U.S. Several U.K.

Vaccines 196

Vaccines Drug Pricing 196

pharmaphorum

APRIL 28, 2024

Pfizer has said it will launch its just-approved haemophilia B gene therapy Beqvez with a warranty programme that will provide “greater certainty” to payers, after setting a price directly in line with a rival treatment.

94

94

STAT

JUNE 26, 2023

Pfizer said Monday that it had discontinued clinical trials of a once-daily weight-loss pill whose results were highly anticipated by investors because patients taking the drug had elevated levels of certain liver enzymes. pounds of weight loss over 16 weeks, had led Pfizer’s stock to jump when they were published in May.

156

156

pharmaphorum

MAY 12, 2024

Pfizer reaches deal with NICE on Vyndaqel for ATTR-CM Phil.Taylor Mon, 13/05/2024 - 04:57 Bookmark this

107

107

pharmaphorum

MAY 6, 2024

Pfizer has named Citi analyst Andrew Baum as its chief strategy and innovation officer, taking point on portfolio management and capital deployment

86

86

Pharmaceutical Technology

APRIL 29, 2024

Pfizer has received approval from the US Food and Drug Administration (FDA) for its one-time gene therapy BEQVEZ for haemophilia B.

98

98

pharmaphorum

APRIL 16, 2024

FDA starts review of GSK’s 5-in-1 meningitis vaccine, cueing up a decision early next year, as it tries to chase down Pfizer's recently-approved Penbraya

Vaccines 97

Vaccines 97

World Pharma News

DECEMBER 15, 2023

Pfizer Inc. NYSE: PFE) announced that its board of directors declared an increase in the quarterly cash dividend on the company's common stock to $0.42 for the first-quarter 2024 dividend, payable March 1, 2024, to holders of the Common Stock of record at the close of business on January 26, 2024.

92

92

Big Molecule Watch

APRIL 29, 2024

(collectively, “BioNTech”), and Pfizer Inc. Pfizer”) related to Moderna’s mRNA technology and the subsequent i nter partes review (IPR) petitions filed by BioNTech and Pfizer. ” The post Moderna Litigation Against BioNTech and Pfizer Stayed Pending IPR appeared first on Big Molecule Watch. .”

Immunity 62

Immunity Immunization 62